Novocure
Cynthia Patterson is an experienced Medical Science Liaison and Thought Leader Liaison currently at Novocure since November 2019, where responsibilities include serving as the scientific interface to healthcare professionals and providing clinical education in Oncology. Prior roles include serving as a Medical Science Liaison and Team Lead at kaleo, focusing on Neurology and Addiction, and as a National Medical Science Liaison with The Medical Affairs Company for BioDelivery Sciences, aiding in the introduction of a pharmaceutical product in the U.S. Prior to these positions, Cynthia had a lengthy tenure at Merck, where roles spanned from Health Science Consultant to Medical Science Liaison across several disease states. Earlier career experience includes leadership in national accounts with Ranger American and Brink’s, as well as entrepreneurship as the Principal Owner of MarComm Industries. Cynthia holds an MBA from Campbell University, a B.S. in Communications and Business from the University of Florida, and an A.A. in Business from Brevard Community College.
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.